Suchergebnisse - "de Azambuja, E"

PubPharm (22)

1

Prognostic value of HER2-low status in breast cancer : a systematic review and meta-analysis

enthalten in: ESMO open | 2023

von Molinelli, C. | Jacobs, F. | Agostinetto, E. | +10

2

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial

enthalten in: ESMO open | 2023

von de Azambuja, E. | Agostinetto, E. | Procter, M. | +19

3

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19 : analysis of the nationwide BSMO-COVID registry providing lessons for the future

enthalten in: ESMO open | 2022

von Geukens, T. | Brandão, M. | Laenen, A. | +25

4

Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer : the end of the debate

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Poggio, F. | Tagliamento, M. | Ceppi, M. | +7

CommentIn: Ann Oncol. 2022 Jun;33(6):658-659. - PMID 35306157

5

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Gennari, A. | André, F. | Barrios, C. | +26

6

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer

enthalten in: ESMO open | 2021

von Condorelli, M. | Bruzzone, M. | Ceppi, M. | +38

7

Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium : a population-based study

enthalten in: ESMO open | 2021

von van Walle, L. | Punie, K. | Van Eycken, E. | +7

8

Impact of ARTs on oncological outcomes in young breast cancer survivors

enthalten in: Human reproduction (Oxford, England) | 2021

von Condorelli, M. | De Vos, M. | Lie Fong, S. | +11

9

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Brandão, M. | Caparica, R. | Eiger, D. | +1

10

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Holmes, E. | Bradbury, I. | Williams, L. | +9

CommentIn: Ann Oncol. 2019 Sep 1;30(9):1415-1416. - PMID 31271411